Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation
|
Sanara MedTech Inc. (WNDM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/16/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
08/14/2023 |
8-K
| Investor presentation, Quarterly results
Docs:
|
"SANARA MEDTECH INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS June 30, December 31, 2023 2022 Assets Current assets Cash $ 6,060,228 $ 8,958,995 Accounts receivable, net 7,141,105 6,805,761 Accounts receivable – related party 20,662 98,548 Royalty receivable 49,344 99,594 Inventory, net 4,420,864 3,549,000 Prepaid and other assets 485,734 1,104,611 Total current assets 18,177,937 20,616,509 Long-term assets Property and equipment, net 1,240,269 1,416,436 Right of use assets – operating leases 2,030,938 806,402 Goodwill 3,601,781 3,601,781 Intangible assets, net 30,143,578 31,509,980 Investment in equity securities 3,084,278 3,084,278 Total long-term assets 40,100,844 40,418,877 Total assets $ 58,278,781 $ 61,035,386 Liabilities and shareholders’ equity Current liabilities Accounts payab..." |
|
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/11/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
08/02/2023 |
8-K
| Quarterly results |
06/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
04/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/21/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/20/2023 |
8-K
| Quarterly results |
03/20/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
02/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
02/24/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
02/22/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
12/16/2022 |
8-K
| Quarterly results |
12/06/2022 |
8-K
| Quarterly results |
11/30/2022 |
8-K
| Quarterly results |
11/15/2022 |
8-K/A
| Quarterly results |
11/14/2022 |
8-K
| Quarterly results |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
08/26/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
08/15/2022 |
8-K
| Quarterly results |
08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
07/15/2022 |
8-K/A
| Quarterly results |
07/14/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
07/05/2022 |
8-K
| Quarterly results |
06/10/2022 |
8-K
| Quarterly results |
06/02/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
05/16/2022 |
8-K
| Quarterly results |
05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
04/29/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/29/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/29/2022 |
8-K
| Quarterly results |
04/08/2022 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs:
|
"SANARA MEDTECH INC. COMMON STOCK WARRANT Original Issue Date: April 4, 2022 Void After: 5 PM Eastern Time on April 22, 2031 This Warrant Is Issued to Furneaux Capital Holdco, LLC by Sanara MedTech Inc., a Texas corporation . The Company hereby certifies as of the Original Issue Date that, for value received, the Holder is entitled, subject to the terms and conditions set forth in this Warrant, to purchase from the Company, at any time on or after the Original Issue Date and in any event not after the Expiration Date , 4,424 duly authorized, validly issued, fully paid, nonassessable shares of the Company’ s Common Stock, par value $0.001 per share , at an initial purchase price per share equal to $7.32 per share. The number of shares of Common Stock and the purchase price thereof shall be ...",
"SANARA MEDTECH INC. COMMON STOCK WARRANT Original Issue Date: April 4, 2022 Void After: 5 PM Eastern Time on August 10, 2030 This Warrant Is Issued to Furneaux Capital Holdco, LLC by Sanara MedTech Inc., a Texas corporation . The Company hereby certifies as of the Original Issue Date that, for value received, the Holder is entitled, subject to the terms and conditions set forth in this Warrant, to purchase from the Company, at any time on or after the Original Issue Date and in any event not after the Expiration Date , 12,301 duly authorized, validly issued, fully paid, nonassessable shares of the Company’ s Common Stock, par value $0.001 per share , at an initial purchase price per share equal to $12.05 per share. The number of shares of Common Stock and the purchase price thereof shall ...",
"Plan”). The purpose of the Plan is to encourage and enable the officers, employees, directors, Consultants and other key Persons of Precision Healing Inc., a Delaware corporation and its Subsidiaries, upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company.",
"Investor Contact:" |
|
|
|
|